omega-3, 1 gr soft gel, twice a day for 12 weeks

2 trials

Sponsors

Yazd Shahid Sadoughi University of Medical Sciences

Conditions

Condition 1: type 2 diabetes. Condition 2: Nonalcoholic fatty liver disease (NAFLD). Non-insulin-dependent diabetes mellitus Fatty (change of) liver, not elsewhere classified (NAFLD)

Phase 3

Effect of omega-3 fatty acid supplementation in patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.

Active, not recruitingIRCT2016102530489N1

Yazd Shahid Sadoughi University of Medical SciencesCondition 1: type 2 diabetes. Condition 2: Nonalcoholic fatty liver disease (NAFLD). Non-insulin-dependent diabetes mellitus Fatty (change of) liver, not elsewhere classified (NAFLD)

Start: 2016-08-22Target: 60Updated: 2018-02-22

The effect of omega 3 polyunsaturated fatty acid supplementation on inflammatory markers and insulin resistanse factors in patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

Active, not recruitingIRCT2017103030489N2

Yazd Shahid Sadoughi University of Medical SciencesCondition 1: type 2 diabetes. Condition 2: Nonalcoholic fatty liver disease (NAFLD). Non-insulin-dependent diabetes mellitus Fatty (change of) liver, not elsewhere classified (NAFLD)

Start: 2016-12-21Target: 48Updated: 2018-02-22

Related Papers

Effect of omega-3 supplementation on cardiometabolic indices in diabetic patients with non-alcoholic fatty liver disease: a randomized controlled trial

BMC Nutrition2021-12-158 citations

Effect of omega-3 supplementation on fatty liver and visceral adiposity indices in diabetic patients with non-alcoholic fatty liver disease: A randomized controlled trial.

2021-07-0327 citations